VISPI FAMILY HOLDING LIMITED – Trademark Portfolio
Entity Type: 03
VISPI FAMILY HOLDING LIMITED holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CQS, CROPIT, and QUEST FOR CYBER EXCELLENCE. The owner is based in Mississauga, ON.
Suite-113
60 Bristol Road East
Mississauga, ON L4Z3K8 , CA
Showing of trademarks Trademarks
Trademark Classifications
VISPI FAMILY HOLDING LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does VISPI FAMILY HOLDING LIMITED have?
VISPI FAMILY HOLDING LIMITED has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does VISPI FAMILY HOLDING LIMITED file in?
VISPI FAMILY HOLDING LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are VISPI FAMILY HOLDING LIMITED's most well-known trademarks?
VISPI FAMILY HOLDING LIMITED's registered trademark portfolio includes well-known marks such as CQS, CROPIT, and QUEST FOR CYBER EXCELLENCE. These are among 3 currently registered trademarks in the portfolio.
What is VISPI FAMILY HOLDING LIMITED's trademark registration success rate?
VISPI FAMILY HOLDING LIMITED has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.